Philips CEO: Expect Modest Revenue Increase for Full Year

The transcript discusses Philips' response to the COVID-19 pandemic, highlighting the demand-supply conflict, revenue impact, and future growth expectations. It covers challenges in ventilator production, the company's dividend strategy, and changes in business operations. The recovery of the China market and global business outlook are also addressed, along with ventilator allocation and pricing issues.

What is Philips' strategy regarding dividends during the pandemic?

In what ways does Philips expect to change its business model post-crisis?

What are the anticipated changes in consumer behavior as a result of the pandemic?

What insights can be drawn from the recovery trends in China regarding Philips' business?